Texas abortion ruling's broader implications for FDA drug approval
RECENT NEWS
Richard Bagger Joins CMPI Board of Directors
Richard Bagger, a well-known and respected expert in healthcare and biopharmaceutical policy, has joined the Center for M... Read more
Reality-Based Healthcare Reform
When it comes to innovation in the development of new medicines, a key focus is on “Real World Evidence,” or data based o... Read more
Inflation Reduction Act’s Medicare drug price negotiation program is unconstitutional
Protecting American health care with true grit... Read more